These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30107219)

  • 21. Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.
    Liu Y; Salituro GM; Lee KJ; Bak A; Leung DH
    AAPS PharmSciTech; 2015 Oct; 16(5):1091-100. PubMed ID: 25690735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.
    Cho Y; Ha ES; Baek IH; Kim MS; Cho CW; Hwang SJ
    Molecules; 2015 May; 20(6):9496-509. PubMed ID: 26020699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
    Fine-Shamir N; Dahan A
    Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation.
    Huo T; Tao C; Zhang M; Liu Q; Lin B; Liu Z; Zhang J; Zhang M; Yang H; Wu J; Sun X; Zhang Q; Song H
    Eur J Pharm Sci; 2018 Mar; 114():74-83. PubMed ID: 29222025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats.
    Wu L; Qiao Y; Wang L; Guo J; Wang G; He W; Yin L; Zhao J
    AAPS PharmSciTech; 2015 Oct; 16(5):1051-8. PubMed ID: 25652729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Oral Bioavailability of Curcumin Using a Supersaturatable Self-Microemulsifying System Incorporating a Hydrophilic Polymer; In Vitro and In Vivo Investigations.
    Jaisamut P; Wiwattanawongsa K; Graidist P; Sangsen Y; Wiwattanapatapee R
    AAPS PharmSciTech; 2018 Feb; 19(2):730-740. PubMed ID: 28975598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of self-microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine.
    Chen Y; Li G; Huang JG; Wang RH; Liu H; Tang R
    Yao Xue Xue Bao; 2009 Jun; 44(6):658-66. PubMed ID: 19806900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a self-emulsifying formulation that reduces the food effect for torcetrapib.
    Perlman ME; Murdande SB; Gumkowski MJ; Shah TS; Rodricks CM; Thornton-Manning J; Freel D; Erhart LC
    Int J Pharm; 2008 Mar; 351(1-2):15-22. PubMed ID: 18024021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterising Drug Release from Immediate-Release Formulations of a Poorly Soluble Compound, Basmisanil, Through Absorption Modelling and Dissolution Testing.
    Stillhart C; Parrott NJ; Lindenberg M; Chalus P; Bentley D; Szepes A
    AAPS J; 2017 May; 19(3):827-836. PubMed ID: 28236228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 800 mg Darunavir tablets prepared by hot melt extrusion.
    Thommes M; Baert L; Rosier J
    Pharm Dev Technol; 2011; 16(6):645-50. PubMed ID: 20731537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flux-Based Formulation Development-A Proof of Concept Study.
    Kádár S; Tőzsér P; Nagy B; Farkas A; Nagy ZK; Tsinman O; Tsinman K; Csicsák D; Völgyi G; Takács-Novák K; Borbás E; Sinkó B
    AAPS J; 2022 Jan; 24(1):22. PubMed ID: 34988721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.
    Yoshida T; Kurimoto I; Yoshihara K; Umejima H; Ito N; Watanabe S; Sako K; Kikuchi A
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1698-705. PubMed ID: 23062024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
    Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
    Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
    Malipeddi VR; Dua K; Awasthi R
    Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
    Mura P; Valleri M; Cirri M; Mennini N
    Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.